Unlock instant, AI-driven research and patent intelligence for your innovation.

Targeted nano-magnetic resonance contrast agent for brain glioblastoma and its preparation and application

A magnetic resonance contrast agent and glioblastoma technology, applied in the field of molecular imaging, can solve the problems of inability to accurately diagnose glioma in the early stage and clearly display the tumor border, and achieve the goal of improving accuracy and safety and promoting concentration Effect

Active Publication Date: 2021-06-04
AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the existing imaging diagnostic technology cannot solve the problem of early and accurate diagnosis of glioma and clear display of tumor boundaries from the molecular mechanism level, and there is no drug delivery system that can target relevant therapeutic drugs to the target area. lesions, so as to realize the integration of imaging and treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeted nano-magnetic resonance contrast agent for brain glioblastoma and its preparation and application
  • Targeted nano-magnetic resonance contrast agent for brain glioblastoma and its preparation and application
  • Targeted nano-magnetic resonance contrast agent for brain glioblastoma and its preparation and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1 Preparation and Characterization of Targeted Nano Magnetic Resonance Contrast Agent

[0040] Preparation of PEG‐USPIO nanoparticles: ultrasmall superparamagnetic iron oxide particles (USPIO), phosphatidylethanolamine‐polyethylene glycol (DSPE‐PEG), phosphatidylethanolamine‐polyethylene glycol‐active ester (DSPE‐PEG) ‐NHS) and immunofluorescence-labeled coumarin 6 or Cy7.5 were mixed in a weight ratio of 4:20:2:1, dissolved in dichloromethane, ultrasonicated for 10 minutes, and 37°C rotary steamed for 60 minutes to remove dichloromethane and formed a film covering the The inner wall of the bottle, water-dispersed film, to obtain water-dispersed nanoparticles;

[0041] Preparation of PEG‐USPIO‐PEPHC1 nanoparticles: Add 50 μL of sulfhydryl-activated short peptide PEPHC1 20 mg / mL to 4 ml of prepared deionized water-dispersed nanoparticles (0.25 mg / mL USPIO), sonicate for 10 min, centrifuge at 12000 rpm at 4 ° C, discard clear, and disperse the precipitate with ...

Embodiment 2

[0043] Example 2 Characterization diagram of magnetic sensitivity and fluorescence characteristics of targeted nano magnetic resonance contrast agent

[0044] Take an appropriate amount of nano-magnetic resonance contrast agent solution samples, prepare different concentrations of PEG-USPIO-PEPHC1 with deionized water, the iron concentration is 0, 5, 10, 20, 40ug / mL, and place them in 2ml centrifuge tubes respectively. Then PEG-USPIO with corresponding iron concentration was configured as a control. The tubes are placed sequentially in plastic test tube racks and placed in boxes filled with water. Deionized water was used as blank control. The clinical 3.0T MR system (Discovery MR750, GE Medical System, USA) and supporting small animal coils were used for T2Map sequence scanning to evaluate the effect of negative reinforcement. The T2Map images were post-processed using GE Function tool 4.6 special software.

[0045] PEG-USPIO-PEPHC1-Cy7.5 Fluorescence Intensity Detection...

Embodiment 3

[0048] Example 3 In vitro cell antibodies and short peptides were used to detect the expression of EGFRvIII mutants

[0049] Detection of cell surface antigen expression

[0050] 1) Inverted fluorescence microscope analysis:

[0051] U87 or U87‐EGFRvIII cells were treated with 1x10 5 The cells were seeded in a 12-well plate at a density, adhered to the wall for 24 hours, discarded the culture medium, washed 3 times with PBS, 3 minutes each time; fixed with 4% paraformaldehyde for 20 minutes, dried naturally for 10 minutes, washed 3 times with PBS, 5 minutes each time; Add immunostaining blocking solution and place at room temperature for 1 hour. After absorbing the blocking solution, add primary antibody and incubate overnight at 4°C; the next day, wash thoroughly with PBS, add secondary antibody, and incubate for 1 hour at room temperature in the dark. After fully washing with PBS, add 1% DAPI staining solution, cell nuclei were stained in the dark for 5 minutes at room t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a targeted nano-magnetic resonance contrast agent for brain glioblastoma and its preparation and application; the magnetic resonance contrast agent is composed of a small molecule with a targeting binding function, a fluorescent marker and a magnetic iron oxide nano-carrier The small molecule with targeted binding function is a short peptide with affinity for EGFRvIII highly expressed on the surface of glioblastoma cells; the fluorescent marker is covalently attached to the surface of the nanocarrier, The short peptides are covalently linked to polyethylene glycol on the surface of the nanoparticles. The contrast agent can be injected intravenously to make the short peptide combine with the highly expressed EGFRvIII on the surface of tumor cells, promote the concentration of nanocarriers in the tumor site, help improve the accuracy and safety of clinical treatment, and provide a basis for the evaluation of the curative effect of tumor radiotherapy and chemotherapy. Improving non-invasive means of visualization for assessment of patient outcomes and outcomes.

Description

technical field [0001] The invention belongs to the technical field of molecular imaging, and relates to a targeted nano-magnetic resonance contrast agent for brain glioblastoma, as well as its preparation and application. Background technique [0002] Glioblastoma is the most common primary brain tumor in adults. Due to its rich blood vessels, infiltration and growth, and easy recurrence, it has become one of the most malignant and difficult to cure tumors, with an incidence rate of 5.26 / 100,000, and 17,000 new clinically confirmed cases are added every year. It accounts for 52% of all primary brain tumors and 20% of intracranial tumors. According to data, the 1-year survival rate of glioblastoma after diagnosis is only about 30%, and the average survival period is only 53 weeks. The average survival period is only 19.6 months. Due to the existence of the blood-brain barrier (BBB), 98% of small molecular compounds and almost all macromolecular substances cannot reach th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K49/14A61K49/12A61K49/00
CPCA61K49/0002A61K49/0039A61K49/0054A61K49/0056A61K49/126A61K49/14
Inventor 张军刘先平王剑虹庞志清耿道颖
Owner AFFILIATED HUSN HOSPITAL OF FUDAN UNIV